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Abstract
Background:  Most emerging health threats are of zoonotic origin. For the overwhelming
majority, their causative agents are RNA viruses which include but are not limited to HIV, Influenza,
SARS, Ebola, Dengue, and Hantavirus. Of increasing importance therefore is a better understanding
of global viral diversity to enable better surveillance and prediction of pandemic threats; this will
require rapid and flexible methods for complete viral genome sequencing.
Results: We have adapted the SISPA methodology [1-3] to genome sequencing of RNA and DNA
viruses. We have demonstrated the utility of the method on various types and sources of viruses,
obtaining near complete genome sequence of viruses ranging in size from 3,000–15,000 kb with a
median depth of coverage of 14.33. We used this technique to generate full viral genome sequence
in the presence of host contaminants, using viral preparations from cell culture supernatant,
allantoic fluid and fecal matter.
Conclusion: The method described is of great utility in generating whole genome assemblies for
viruses with little or no available sequence information, viruses from greatly divergent families,
previously uncharacterized viruses, or to more fully describe mixed viral infections.
Background
The emergence of highly pathogenic viral agents from
zoonotic reservoirs has energized a wave of research into
viral ecology, viral discovery [4-7] and a parallel drive to
develop large datasets of complete viral genomes for the
study of viral evolution and pandemic prediction [8,9].
Viral discovery has been aided by the development of
sequence independent methodologies for the generation
of genomic data [10]. The most prominent of these meth-
odologies include representational difference analysis
(RDA) and sequence independent single primer amplifi-
cation (SISPA) with several variations. The SISPA method,
first developed by Reyes and Kim [11], entails the direc-
tional ligation of an asymmetric primer at either end of a
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blunt-ended DNA molecule. Following several cycles of
denaturation, annealing and amplification, minute
amounts of the initial DNA are enriched and then cloned,
sequenced and analyzed. Several modifications of the
SISPA method have so far been implemented including
random-PCR (rPCR) [12]. The rPCR method combines
reverse transcription primed with an oligonucleotide
made up of random hexamers tagged with a known
sequence which is subsequently used as a primer-binding
extension sequence. This initial modification was first
used to construct a whole cDNA library from low amounts
of viral RNA. A more recent modification, the DNAse-
SISPA technique [1,2,5], includes steps to detect both
RNA and DNA sequences. Combining sample filtration
through a 0.22 micrometer column and a DNAse I diges-
tion step led to the identification of viruses from clinical
samples. The DNase-SISPA technique has been used for
the detection of novel bovine and human viruses from
screens of clinical samples [1,2,13]. Other groups have
used the protocol for the characterization of common
epitopes in enterovirus [14], for the identification of a
novel human coronavirus [15] and for viral discovery in
the plasma of HIV infected patients [16].
In addition to its utility for viral discovery and viral sur-
veillance, the DNase-SISPA method has utility in obtain-
ing full genome sequence from uncharacterized viral
isolates or viral isolates from highly divergent families. In
this study, we demonstrate the utility of the SISPA method
and its use as a rapid and cost effective method for gener-
ating full genome coverage of a wide range of viral types
from several sources.
Results and discussion
Optimization of the SISPA method for whole genome 
sequencing
Given the success of earlier efforts for the identification of
novel viral nucleic acids using SISPA, we sought to adapt
and optimize this method as a general and cost effective
technique for large scale de novo viral genome sequencing
(Figures 1 and 2). An RNase treatment step was added to
the SISPA protocol to reduce contaminating exogenous
RNAs such as ribosomal RNAs. In the case of polyA-tailed
viruses, we perform reverse transcription using a combi-
nation of random (FR26RV-N) and poly T tagged
(FR40RV-T) primers in order to increase the coverage of
the 3' end (Figure 2). Additionally, in order to capture 5'
ends of viral RNA, a random hexamer primer tagged with
a conserved sequence at the 5' end was added to the Kle-
now reaction (Figure 2 shows a 5' oligo specific for rhino-
viruses).
Viral genome assembly metrics
We have successfully used the SISPA method on viral sam-
ples from different viral types. In this paper we discuss
seven representative samples (Table 1). We have found
that the method works consistently on dsDNA, ssDNA,
ssRNA positive and ssRNA negative viruses. We have also
found that the method can result in complete genome
sequence of viruses ranging in size from 3,000–15,000 kb
in a single experimental procedure. Figure 3 shows the
sequence coverage obtained for three viruses: positive
ssRNA phage MS2, positive ssRNA rhinovirus and nega-
tive ssRNA Newcastle disease virus (NDV).
Figure 4A shows an analysis of sequence coverage for the
viruses examined in this study. On average, four contigs
were generated per experiment, ranging in size from 248
nt to 4495 nt with a median contig size of 1395 nt. The
contigs had high sequence redundancy, with a median
depth of coverage of 14.33, varying from 11.18 for turkey
astrovirus (TA) to a high of 40.29 for MS2.
One parameter that is taken into consideration when
designing an efficient protocol for construction of a
sequence library is the number of independent colonies
needed to obtain sequence coverage of a given reference
genome. Experiments were conducted using M13 (a 6 kb
g e n o me ) ,  N D V  ( a  15  k b  g e no m e ) ,  a n d l a m b d a  p h ag e
(48.5 kb) to compare the level of coverage obtained by
bidirectional sequencing of 96, 192, and 288 clones (Fig-
ure 4B). For M13, 94% genome coverage was achieved
from sequencing one 96 well block of clones, and 97%
genome coverage was obtained from two 96 well blocks.
For NDV, 89.7%, 97.4% and 97.7% sequence coverage
were obtained from one, two or three 96 well blocks
respectively. In contrast to M13 and NDV, the coverage for
lambda was 26.7%, 42.9%, and 52.4% after one two and
three 96 well blocks were sequenced
The efficiency of the SISPA method as a tool for obtaining
full genome coverage was analyzed using the Lander and
Waterman model [17], which estimates the number of
gaps present as a function of sequence number and
genome size. Table 2 compares the expected coverage and
redundancy (depth of coverage) as predicted by the
Lander-Waterman model with the observed genome cov-
erage and redundance. With the exception of lambda
phage, observed coverage and redundancy approach
expected coverage and redundancy.
However when taking into account the scaled difference,
as described by Wendl [18], we see a dramatically
increased "shortfall" between actual and expected cover-
age as more clones are sequenced. For example, in the case
of NDV which has a genome size of 15 Kb, the scaled dif-
ference D between the expected coverage and the observed
coverage (see equation description in methods section) at
the different levels of sequence redundancy is 48.3 for theBMC Genomics 2008, 9:5 http://www.biomedcentral.com/1471-2164/9/5
Page 3 of 9
(page number not for citation purposes)
sequencing of a plate of 96 clones, 464.4 for two plates
and 5477.4 for three plates.
The SISPA method works efficiently on viruses purified
from a number of sources and by several methods. Entero-
bacteriophages M13, MS2, and lambda were isolated
from bacterial growth media and plasma after concentra-
tion by density gradient centrifugation. Woodchuck hep-
atitis virus was purified from plasma by cesium chloride
gradient centrifugation. Human rhinovirus 16, purchased
as a cell culture supernatant from ATCC, was subjected to
a low speed spin to remove cellular debris. Turkey astrovi-
rus was isolated from fecal material collected from turkey
poults showing clinical signs of diarrhea. The intestinal
fecal content was diluted in PBS and centrifuged at 14,000
K before filtration and nuclease treatment. Newcastle dis-
ease virus RNA was purified from allantoic fluids derived
from inoculated eggs.
To determine the number of viral particles necessary to
generate full genome sequences, we conducted dilution
series with viruses whose titer was determined by plaque
assays. The results of these experiments demonstrate that
the SISPA method is very efficient as a genome sequencing
method for samples with greater than 106 viral particles
per RT-PCR reaction (Figure 5). Below 106 particles, the
specific viral signal is overwhelmed by competition with
non-specific or host sequences and is rarely detected from
sequencing two blocks (192) of colonies.
Resolution of 3' and 5' ends
Our initial results indicated low sequence coverage at the
3' and 5' ends of most viral genomes. In order to address
Overview of the strategy Figure 1
Overview of the strategy. Viral particles are separated from host contaminants using centrifugation and filtration. Viral par-
ticles are treated with DNAse I to remove contaminated nucleic acids. Random priming is used to generate 500–1000 bp 
amplicons which are size-selected and cloned. Colonies are picked and sequenced. Sequence is trimmed and assembled. Con-
tigs are closed using sequence-specific primers.
Pooled or Individual Samples
If sample volume > 1 ml If sample volume ~ 0.2 ml If sample volume < 0.2 ml
Centrifuge at 45,000 rpm
and resuspend pellet with
0.2 ml with 2% NHS 
Complete sample volume to 
0.2 ml with 2% NHS 
Filter sample through a 0.22 µm filter
DNAse I treatment for 1 hour at 37oC
Preparation of 
viral DNA
Preparation of
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Amplification by “random PCR”
Construction of a library of amplicons and sequencing of 
randomly selected clones
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this problem in viruses with polyA tails the FR40RV-T
primer (Figure 2) is added to the RT reaction. This
increases the number of cDNAs produced at the 3' end of
the genome, and results in a much greater depth of cover-
age at the 3' end. The polyT containing primer is added to
the RT reaction at a concentration 200 fold lower than the
random primer in order to reduce competition with the
random primer.
We used human rhinoviruses to develop the methodology
for improving the coverage of the 5' end. We took advan-
tage of a conserved region from nucleotide 1 to nucleotide
10 in the 5' untranslated region. The conserved primer
was used in the Klenow step of the SISPA protocol to
enrich for the presence of amplicons from the 5' end.
When used in combination with the 3' primer, we have
been able to obtain full rhinovirus genome coverage in a
192 clone experiment (data not shown).
Contaminant sequences
One inherent difficulty of a method that relies on a ran-
dom reverse transcription and PCR to generate amplicons
for sequencing is the likelihood of detecting contaminant
sequences as well as sequences of interest. Although filtra-
tion and nuclease treatment does reduce the presence of
nucleic acids from whole cells and host chromosomes,
contaminating RNA species will inevitably remain and
thus be amplified (Table 3).
To determine the presence of contaminant sequences in
the clone population, all generated sequences were sub-
jected to a blastn search against the NCBI (non-redun-
dant) database. A cutoff e value of 10-25 was used to
identify viral sequences which matched the reference
genome. Non-specific sequences (i.e., those that did not
match the input viral isolate) were identified as mamma-
lian, avian, bacterial, etc., if their best hit was below a cut
off value of 10 -10. If no blast results were found below the
10 -10 cut off value the sequences were not given a specific
designation. In experiments resulting in nearly complete
genome sequences, contaminant sequences ranged from
3–40%. The nature of the contaminant sequence
depended on the initial viral host and included mamma-
lian, avian, bacterial, fungal, viral and unknown
sequences. In the case of rhinoviruses, which were puri-
fied from HeLa cell culture, the majority of contaminant
was of derived from human or mycobacterial nucleic
Table 1: Viral isolates discussed in this study.
Virus Name Viral Type Genome Size Viral Particles
Woodchuck hepatitis virus (WHV) dsDNA 3308 n/a
Enterobacteriophage MS2 (MS2) ssRNA positive 3569 108
Enterobacteriophage M13 (M13) ssDNA 6407 108
Human Rhinovirus 16 (HRV16) ssRNA positive 7124 n/a
Turkey Astrovirus (TA) ssRNA positive 7355 n/a
Newcastle disease virus (NDV) ssRNA negative 15186 n/a
Bacteriophage lambda (lambda) dsDNA 48502 108
Outline of the SISPA method Figure 2
Outline of the SISPA method. A. Viral RNA is converted 
to cDNA using random-tagged and poly-A tagged primers 
(FR26RV-N and FR40RV-T). B. Second strand DNA is syn-
thesized using Klenow exo-DNA polymerase, in the pres-
ence of random tagged and virus specific 5' end oligo 
primers. C. Double stranded DNA is amplified by PCR using 
the primer tag (FR20RV). D. Amplicons are separated by 
electrophoresis and products ranging from 500–1000 nucle-
otides are cloned into the TOPO vector. 96–288 colonies 
are picked, plasmid DNA is purified and the inserts are 
sequenced.
Random (FR26RV-N):  
5’GCC GGA GCT CTG CAG ATA TCN NNN NN 3’
3’ primer (FR40RV-T): 
5’GCC GGA GCT CTG CAG ATA TC TTT TTT TTT TTT TTT TTT TT 3’
Reverse Transcription
(using random and 3’ primers)
Single-
stranded
cDNA Klenow Reaction
(using random and 5’ primers)
Double-
stranded
cDNA
PCR and A-tailing
A A
A
A
A A
A
A
A A
A
A A
A
A A
TA Cloning of 500 – 1000 nt 
amplicons and sequencing
PCR 
amplicons
Viral RNA (AAAAAA)n A
B
C
D
Virus specific 5’primer(e.g. rhinovirus):
5’GCC GGA GCT CTG CAG ATA TC TTA AAA CTG G 3’BMC Genomics 2008, 9:5 http://www.biomedcentral.com/1471-2164/9/5
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acids. Newcastle (NDV) and astrovirus (TA) which were
purified from chicken egg allantoic fluid and turkey feces,
respectively, were contaminated primarily with nucleic
acids of avian origin. Table 3 shows the results of blast
analyses of two samples, TA and HRV16.
Conclusion
The work presented here demonstrates the utility of the
random genome sequencing method for the generation of
viral sequence from positive strand ssRNA (Human Rhi-
novirus, Turkey astrovirus) and negative strand ssRNA
viruses (Newcastle disease virus), ssDNA (enterobac-
teriphage M13) and dsDNA viruses (woodchuck hepatitis
virus and lambda phage). In addition, using the DNase I-
SISPA technique we were able to amplify sufficient target
material for sequencing from various sources, including
cell culture isolates and field isolates which have not been
purified by ultracentrifugation. Although ultracentrifuga-
tion is an efficient procedure to purify viruses, it is not
practical for processing samples of relatively low viral titer
in a small volume or high throughput processing of viral
samples for genomic sequencing.
Genome coverage and redundancy for viral samples from
3–15 kb approach the ideal values as predicted by the
Lander-Waterman model [17]. However, as the sequence
number increases, the efficiency of the method as meas-
A. Depth of coverage of viruses Figure 4
A. Depth of coverage of viruses. Depth of coverage sta-
tistics were generated for each contig (using the output of 
DNAStar Seqman program). Average coverage is the 
summed length of all sequence reads in a contig, including 
gaps divided by the contig length. The average and standard 
deviation for each virus was determined. B. Correlation of 
genome coverage with colonies picked. The SISPA 
method was performed for enterobacteriophage M13 (6407 
bp), Newcastle disease virus Lasota (15,186 bp) and entero-
bacteriophage lambda (48502 bp). One, two or three 96-well 
blocks of clones were sequenced, trimmed and assembled. 
The sum of the total lengths of edited contigs for each condi-
tion was calculated as percent of the total reference genome 
length.
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Representative assemblies of viruses described in this study Figure 3
Representative assemblies of viruses described in this 
study. Images shown were generated using DNASTAR Seq-
man program. A. Enterobacteriophage MS2 (3569 bp). B. 
Human Rhinovirus 16 (7124 bp). C. Newcastle disease virus 
Lasota (15186 bp). All assemblies have been aligned with 
their reference genomes. Gaps and low coverage areas which 
require closure are circled.
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ured by the scaled difference [18] decreases dramatically.
Thus, while the number of gaps declines as more clones
are sequenced, the efficiency is reduced (i.e. there is more
'loss'. Remaining gaps and areas of 1× coverage may be
due to regions of secondary structure, hydrolysis of the
RNA template or cloning bias. Additionally, AT rich
regions may inhibit the annealing of random primers dur-
ing the RT, Klenow or PCR step. We routinely pick a total
of 192 clones (or two 96 well blocks) per viral sample for
bidirectional sequencing as this represents the most
affordable sequence coverage to efficiency ratio. While sig-
nificant coverage is obtained from a single experiment,
final genome assembly requires varying levels of targeted
RT-PCRs to close the genome (Figure 3).
The 3' end of the virus generally has the lowest coverage
in any use of this protocol. In theory, given the direction-
ality of the reverse transcriptase (3' to 5') and assuming an
equal distribution of binding sites for the random primer,
the 5' end of any viral genome will get higher depth of
sequence coverage than the 3' end. We have found that
addition of a tagged oligo dT primer significantly reduces
this problem for viruses with polyA tails (most positive
ssRNA viruses), but this remains a limitation for other
virus genome types. The 5' end of most viruses has also
proved difficult to complete and we have found that the
addition to the RT reaction of degenerate oligos based on
conserved 5' sequences can increase coverage. However
we have not been able to develop a universally applicable
method for obtaining complete 5' coverage. We strongly
anticipate that specific adaptations of the SISPA method
to conserved regions of different viruses will demonstrate
its versatility in a wide range of viral genome sequencing
initiatives.
Limitations to the method include the need for samples
containing a minimum of 106 particles (in the original 1
ml or 0.2 ml samples). Moreover because the capsid struc-
ture renders the viral genomes nuclease-resistant, this pro-
tocol requires encapsidated viral genomes to allow the
removal of most extra-viral contaminants. The viral
nucleic acids in samples whose capsid structures have
been disrupted cannot be separated from contaminants,
and therefore cannot be efficiently amplified by SISPA. In
the experiments discussed in this paper DNAse I was used
to reduce host contaminant. For samples with high levels
of host nucleic acid contaminant, we have used 5 µg of
RNAse A to treat 500 µl of filtered virus for 1 hr. We have
found that RNAse A treatment eliminates the majority of
host RNA derived sequence contaminant in these cases.
The SISPA method is particularly useful for obtaining
genome sequence from RNA viruses. Because most
sequencing methods for RNA viruses depend on RT-PCR
with primers designed from pre-existing sequence data,
Relationship between initial virus particle number, genome  coverage and percent non-specific sequences generated by  SISPA Figure 5
Relationship between initial virus particle number, 
genome coverage and percent non-specific 
sequences generated by SISPA. MS2 viruses were 
diluted to 108, 106, 104, and 102 particles per SISPA DNAse I 
reaction. The sum of the total lengths of edited contigs for 
each dilution was calculated as percent of the total reference 
genome length. Non-specific sequences were determined as 
those sequences which did not match reference genome with 
a cutoff value less than 10-25.
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Table 2: Lander-Waterman analysizs of viral genome coverage.
Virus Name Total Sequences Observed Coverage Expected Coverage Observed 
Redundancy
Expected Redundancy
WHV 121 0.84 1.00 14.86 18.45
MS2 283 0.93 1.00 40.29 40.20
M13 232 0.90 1.00 21.26 18.36
HRV 16 195 0.90 1.00 14.33 13.88
TA 148 0.93 1.00 11.29 10.22
NDV 349 0.97 1.00 13.72 11.65
Lambda 281 0.52 0.95 3.72 2.92
Observed coverage and redundancy was compared with the expected coverage and redundancy as predicted by the Lander-Waterman model for 
the total number of sequences in each assembly.BMC Genomics 2008, 9:5 http://www.biomedcentral.com/1471-2164/9/5
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the utility of this protocol is particularly evident for highly
variable or degenerate viral families or for viruses with lit-
tle available sequence information. In addition, the SISPA
method will be useful for uncharacterized viruses as no
prior sequence information is required.
Methods
Preparation of viral nucleic acids
Viral RNA and DNA was prepared following the guide-
lines provided by [1,2] with some modifications. Culture
supernatants purchased from the American Tissue Culture
Collection (ATCC) and other virus-containing biological
samples were prepared for viral RNA and DNA extraction.
Each biological sample was first spun to remove cellular
debris and processed through a 0.22 µM filter to enrich
viral particles in the flow-through while retaining bacte-
rial and other large cells in the filter. When necessary, viral
particles were concentrated by ultracentrifugation at 149,
000 × g (45, 000 RPM in a 70.ti Beckman rotor) and the
pellet was resuspended in 200 µl of 2% Normal Human
Serum prepared in sterile water. To eliminate residual
nucleic acid contaminants in the filtrate, 100 units of
DNAse I and/or 10 µg/ml RNAse A was added to the viral
resuspension and was incubated at 37°C for 1 hour. RNA
and/or DNA was then isolated from the sample. For viral
RNA preparation, the Trizol-LS reagent (Invitrogen) was
used according to the manufacturer's instructions. The
RNA pellet was resuspended in 20 µl of nuclease-free
water. To prepare viral DNA, the QIAmp DNA Preparation
kit (Qiagen, Cat. # 51104) was used as recommended and
the DNA was eluted with 50 µl of nuclease-free water.
Table 3: Specific sequences and contaminants in turkey astrovirus and human rhinovirus 16 assemblies.
TURKEY ASTROVIRUS
Contig Length Sequence reads Best Hit
689 2 Avian
501 2 None
423 2 None
518 2 None
259 2 None
1267 28 Turkey astrovirus
2785 67 Turkey astrovirus
1692 43 Turkey astrovirus
Total Sequences 148
Percent Specific 93.24%
Genome coverage 90.84%
HUMAN RHINOVIRUS 16
Contig Length Sequence Reads Best Hit
265 8 Mammalian
537 2 Mammalian
981 27 Mammalian
1091 7 Bacterial
1297 10 Bacterial
553 1 None
385 1 None
342 3 None
815 32 None
909 18 None
676 8 None
487 9 None
4823 105 Human Rhinovirus 16
1685 90 Human Rhinovirus 16
Total Sequences 321
Percent Specific 60.75%
Genome coverage 90.23%
Sequences were analyzed against a non redundant database using a blastn algorithm. Viral specific sequences were identified as matching the 
reference genome with a blastn cut off below 10-25. Non-specific (non-viral contaminant) sequences were identified if they had a cut off value below 
10-10, while None means that no blastn results were found below the 10-10 cut off value.BMC Genomics 2008, 9:5 http://www.biomedcentral.com/1471-2164/9/5
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Construction of a library of random PCR fragments and 
sequencing
The extracted RNA was processed for random reverse tran-
scription as previously described [1,2] using the FR26RV-
N primer (5' GCC GGA GCT CTG CAG ATA TCN NNN
NN 3') at a concentration of 1 µM. In addition, FR40RV-T
(5' GCC GGA GCT CTG CAG ATA TC (T)20 3') was added
at a concentration of 5 nM to specifically amplify the 3'
end of positive strand viruses. After the first cDNA synthe-
sis, the double stranded cDNA was synthesized by Klenow
reaction the presence of random primers. In order to
amplify 5' ends of rhinoviruses the following primer was
added to the Klenow reaction at a concentration of 10–20
nM (5'GCC GGA GCT CTG CAG ATA TC TTA AAA CTG G
3'). PCR amplification used high fidelity Taq Gold DNA
polymerase (ABI) with the FR20RV primer (5' GCC GGA
GCT CTG CAG ATA TC 3'). PCR amplicons were A-tailed
with dATP and 5 units of low fidelity DNA polymerase
(Invitrogen) at 72°C for 30 minutes. A-tailed PCR ampli-
cons were analyzed in a 1% agarose gel and fragments
between 500 and 1000 nt were gel purified. Amplicons
were ligated en masse into the Topo TA cloning vector (Inv-
itrogen) and transformed into competent one shot Topo
top 10 bacterial cells (Invitrogen). For DNA viruses, the
purified viral DNA was denatured and complementary
strands synthesized by Klenow reaction as indicated for
ds-cDNA from first strand cDNA. Clones were plated on
LB/Amp/XGal agar, and individual colonies were picked
for sequencing. The clones were sequenced bidirectionally
using the M13 primers from the topo TA vector. We rou-
tinely sequenced a total of 192 or more per library.
Sequencing reactions were performed at the Joint Tech-
nology Center (an affiliate of the J Craig Venter Institute:
JCVI) on an ABI 3730 xl sequencing system using Big Dye
Terminator chemistry (Applied Biosystems).
Analysis of genome coverage
In the Lander and Waterman analysis of genome coverage
[17] G = Size (bp) of Reference Genome, L = Sequence
Length (bp) and N = # sequences; Redundancy represents
the depth of sequence coverage and Coverage represents
the fraction of genome covered by sequence data.
The Ideal Redundancy (R) = LN/G and the Ideal Coverage
= 1-e-R [17]
Observed Coverage = sum of the length of all contigs/G.
Observed Redundancy = the average of total sequence
length (length of all sequence reads in a contig including
gaps)/contig Length. Both Observed coverage and
Observed Redundancy are experimentally derived values.
The average sequence read size for the experiments
described was 507.83 +/- 47.16 bp.
The loss of coverage due to various biases is represented as
the difference between the ideal coverage and the actual
coverage. To allow quantitative comparison, this 'short-
fall' difference is scaled by the standard deviation of the
coverage probability distribution as given by Wendl [18].
Following Wendl, we use the moments of the vacancy
(which is the complement of the coverage) to calculate the
standard deviation.
EV = (1 - α)N
Where α is the ratio of the read length and the genome
length and N is the number of reads.
The second moment is given as:
EV2 = exp(-2ρ) + 2/N·exp(-ρ)
Where ρ, the redundancy, is define to be equal to Nα
The expression for the variance is then:
σ2 = (1 - α)2N - exp(-2ρ) + 2/N·exp(-ρ))
The standard deviation is then:
The ideal coverage is given by:
EC = 1 - exp(-ρ)
Using the standard deviation for the vacancy in place of
that for the coverage, the correctly-scaled difference D
between ideal coverage and the actual coverage A is:
D = (EC - A)/S
Note that for large N the mean vacancy converges to exp(-
ρ) allowing the following simplified approximation of S:
Assembly of viral genomes
Sequence reads were trimmed to remove amplicon primer
sequence as well as low quality sequence, and assembled.
A small genome assembler called Elvira (Executive for
Large-scale Viral Assembly), based on the open-source
Minimus assembler, was developed to automate these
tasks. For some figures images were generated using the
SeqMan II sequence analysis software, DNASTAR Inc.
1989–2002.
S exp N exp
N =− − −+ ⋅− ()( ( ) / ( ) ) 12 2
2 αρ ρ
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Reference genomes
The following complete genomes were used as reference
genomes for the viruses discussed in this study: Wood-
chuck hepatitis virus (AY628095); Enterobacteriophage
MS2 (NC_001417); Enterobacteriophage M13
(NC_003287); Human Rhinovirus 16 (L24917); Turkey
Astrovirus (NC_002470);
Newcastle disease virus LaSota (AY845400) Enterobacte-
ria phage lambda (NC_001416)
List of abbreviations
SISPA: Sequence-independent single primer amplifica-
tion; rPCR: Random polymerase chain reaction; RT:
Reverse transcription; NDV: Newcastle disease virus
LaSota; TA: Turkey astrovirus 2; HRV: Human rhinovirus.
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